Oncology ImagingArchives
Diagnostic value of ultrasound peritumoral viscoelasticity parameters in breast cancer: enhancing BI-RADS classification performance
Oncology Imaging 5 min.
Breast cancer remains the most prevalent malignancy and leading cause of cancer-related mortality among women globally, with the World Health Organization (WHO) underscoring early detection as a critical determinant for improving prognostic outcomes and survival rates [1]. The histological examination...
MRI-Based peritumoral radiomics for predicting recurrence risk in ER+/HER2- breast cancer
Oncology Imaging 5 min.
With 2.3 million new cases occurring in 2020, breast cancer is the most common cancer worldwide [1], and rational treatment can help reduce recurrence and improve prognosis [2]. With the development of molecular techniques, breast cancer has been shown to be a highly heterogeneous tumor [3], which poses...
Tumor heterogeneity index from DCE-MRI for AKT-inhibition responder identification and reveals hot immune microenvironment for patients with breast cancer: a multi-omics analysis of I-SPY2 trial
Oncology Imaging 7 min.
The AKT/mammalian target of rapamycin (mTOR)/phosphatidylinositol-3-kinase (PI3K) signaling pathway plays a crucial role in the development, survival, and proliferation of tumor cells [1]. As a central component of the AKT/mTOR/PI3K pathway, AKT serves as an essential mediator that transmits signals...
Pleural ultrasound as an adjunct to physical examination in the preoperative evaluation of lung cancer patients
Oncology Imaging 1 min.
Preoperative evaluation of patients with suspected or confirmed lung cancer consists of clinical and radiological staging. Malignant pleural effusion is a poor prognosticator in non-small-cell lung cancer. Pleural ultrasound (PU) allows for the assessment of pleural effusion, providing real-time guidance...
Enhancing breast cancer diagnosis: non-invasive prediction of MKI-67 (Ki67) expression using ultrasound images
Oncology Imaging 9 min.
Breast cancer is one of the most common malignant tumors among women [1]. In 2020, approximately 685,000 people worldwide died from breast cancer [2]. In China, breast cancer accounts for about 10% of various malignant tumors, and the growth rate is increasing year by year, and the age of onset of patients...
